Gene · 23089
PEG10: paternally expressed 10
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PEG10: paternally expressed 10. Genes, record 23089. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23089
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q86TG7 | Retrotransposon-derived protein PEG10 | 708 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents11
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025517657 A | 2025-06-10 | 22 | Q86TG7 | Espacenet |
| WO 2025097132 A1 | 2025-05-08 | 70 | Q86TG7 | Espacenet |
| JP 2022147356 A | 2022-10-06 | 220 | Q86TG7 | Espacenet |
| JP 2022517803 A | 2022-03-10 | 8 | Q86TG7 | Espacenet |
| WO 2020148310 A1 | 2020-07-23 | 6 | Q86TG7 | Espacenet |
| JP 2020062004 A | 2020-04-23 | 1425 | Q86TG7 | Espacenet |
| US 10533225 B2 | 2020-01-14 | 123 | Q86TG7 | Espacenet |
| EP 3258268 A1 | 2017-12-20 | 185 | Q86TG7 | Espacenet |
| US 9677138 B2 | 2017-06-13 | 123 | Q86TG7 | Espacenet |
| WO 2016103269 A1 | 2016-06-30 | 2903 | Q86TG7 | Espacenet |
1 to 10 of 11
See all 11 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants820
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PEG10 papers | Newest fiscal year |
|---|---|---|---|
| P30ES025128 | Center for Human Health and the Environment (CHHE) | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30ES017885 | Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) | 6 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 3 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 3 | 2025 |
| P01AG019724 | Frontotemporal Dementia: Genes, Images, and Emotions | 2 | 2025 |
| P01AI120943 | Molecular Mechanisms of Filoviral-host Interactions | 2 | 2025 |
1 to 10 of 820Source NIH's project files
See all 820 nih grantsPapers1,379
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Placenta-Related PEG10 Inhibits mRNA Decay to Promote Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. | Cancer Res | 2026 | 42826094 | PubTator, text mining | PubMed |
| Structure-guided antisense oligonucleotides selectively modulate frameshifting of a human gene. | bioRxiv | 2026 | 42818233 | PubTator, text mining | PubMed |
| MicroRNA-122 as a regulator and biomarker of liver disease. | J Mol Med (Berl) | 2026 | 42760391 | PubTator, text mining | PubMed |
| Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer. | Am J Transl Res | 2026 | 42631165 | PubTator, text mining | PubMed |
| Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells. | Front Oncol | 2026 | 42568401 | PubTator, text mining | PubMed |
| Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control. | Tissue Eng Regen Med | 2026 | 42467368 | PubTator, text mining | PubMed |
| Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer. | Cancer Lett | 2026 | 42457019 | PubTator, text mining | PubMed |
| Integrative transcriptomic and CRISPR dependency analysis identifies hepatoblastoma-specific essential genes and actionable vulnerabilities. | Cancer Genet | 2026 | 42385356 | PubTator, text mining | PubMed |
| Hypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1/FAK/PI3K/AKT pathway. | Biol Direct | 2026 | 42310796 | PubTator, text mining | PubMed |
| Engineering human PEG10-based nanoparticles for RNA self-packaging, delivery and cancer therapy. | Nat Commun | 2026 | 42285982 | PubTator, text mining | PubMed |
1 to 10 of 1,379
See all 1,379 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23089
GET https://conductscience.org/api/genes/v1/23089/patents